Načítá se...
Treatment of immunocompromised COVID‐19 patients with convalescent plasma
Immunosuppressed patients such as solid organ transplant and hematologic malignancy patients appear to be at increased risk for morbidity and mortality due to coronavirus disease 2019 (COVID‐19) caused by SARS coronavirus 2 (SARS‐CoV‐2). Convalescent plasma, a method of passive immunization that has...
Uloženo v:
| Vydáno v: | Transpl Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537112/ https://ncbi.nlm.nih.gov/pubmed/32989856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13477 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|